Patents by Inventor Toshihiro Noguchi

Toshihiro Noguchi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20190065425
    Abstract: An information processing device includes a buffer that stores data blocks of a plurality of flows and from which the data blocks are sequentially read; a processor coupled to the buffer and configured to: monitor an input rate that is a sum of data amounts of the plurality of flows input to the buffer per unit of time, and suppress flowing of a data block into the buffer for one or more of the plurality of flows based on a result of monitoring the input rate.
    Type: Application
    Filed: August 10, 2018
    Publication date: February 28, 2019
    Applicant: FUJITSU LIMITED
    Inventors: Tsutomu Noguchi, Toshihiro Noguchi, Toshimi Kida, Naoki Fukuda, Naoki Kawasaki, AKIKAZU MAEHARA, Masamichi Kasa
  • Patent number: 9139658
    Abstract: A medicament for treating cancer for use in combination therapy with an anti-HER2 antibody, which comprises amrubicin or a pharmaceutically acceptable salt thereof as an active ingredient.
    Type: Grant
    Filed: December 23, 2010
    Date of Patent: September 22, 2015
    Assignee: SUMITOMO DAINIPPON PHARMA CO., LTD.
    Inventors: Toshihiro Noguchi, Akemi Baba, Mitsuharu Hanada
  • Patent number: 8287918
    Abstract: Lung cancer can be treated effectively by combination of amrubicin or a pharmaceutically acceptable salt thereof with cisplatin.
    Type: Grant
    Filed: December 14, 2009
    Date of Patent: October 16, 2012
    Assignee: Dainippon Sumitomo Pharma Co., Ltd.
    Inventors: Toshihiro Noguchi, Akemi Baba
  • Publication number: 20110104160
    Abstract: A medicament for treating cancer for use in combination therapy with an anti-HER2 antibody, which comprises amrubicin or a pharmaceutically acceptable salt thereof as an active ingredient.
    Type: Application
    Filed: December 23, 2010
    Publication date: May 5, 2011
    Applicant: Dainippon Sumitomo Pharma Co., Ltd.
    Inventors: Toshihiro NOGUCHI, Akemi Baba, Mitsuharu Hanada
  • Patent number: 7907843
    Abstract: In a point-to-multipoint network of an optical line terminal (OLT) and multiple optical network units (ONUS) wherein each ONU is enabled to send a signal only within a time period enabled for the ONU, the OLT (or a system installed therein) identifies a defective one of the ONUs. For each of a given series of time periods, the OLT measures an optical reception level of an optical fiber signal in the time period. The OLT stores, in advance, in a table at least the reception level of a received signal from each ONU in association with the ONU. The reception level is measured in a normal state where signals from the ONUs are exclusively received. For each of the given series of time periods, the OLT decides whether a signal from one of the ONUs associated with the time period is exclusively received with no collision with any other signal.
    Type: Grant
    Filed: September 27, 2007
    Date of Patent: March 15, 2011
    Assignee: Fujitsu Limited
    Inventors: Katsuichi Yamaji, Toshimi Kida, Toshihiro Noguchi
  • Patent number: 7879327
    Abstract: A medicament for treating cancer for use in combination therapy with an anti-HER2 antibody, which comprises amrubicin or a pharmaceutically acceptable salt thereof as an active ingredient.
    Type: Grant
    Filed: June 11, 2007
    Date of Patent: February 1, 2011
    Assignee: Dainippon Sumitomo Pharma Co., Ltd.
    Inventors: Toshihiro Noguchi, Akemi Baba, Mitsuharu Hanada
  • Publication number: 20100092579
    Abstract: Lung cancer can be treated effectively by combination of amrubicin or a pharmaceutically acceptable salt thereof with cisplatin.
    Type: Application
    Filed: December 14, 2009
    Publication date: April 15, 2010
    Applicant: DAINIPPON SUMITOMO PHARMA
    Inventors: Toshihiro NOGUCHI, Akemi Baba
  • Patent number: 7659257
    Abstract: Lung cancer can be treated effectively by combination of amrubicin or a pharmaceutically acceptable salt thereof with cisplatin.
    Type: Grant
    Filed: January 29, 2002
    Date of Patent: February 9, 2010
    Assignee: Dainippon Sumitomo Pharma Co., Ltd.
    Inventors: Toshihiro Noguchi, Akemi Baba
  • Patent number: 7449181
    Abstract: A medicament for treating cancer for use in combination therapy with an anti-HER2 antibody, which comprises amrubicin or a pharmaceutically acceptable salt thereof as an active ingredient.
    Type: Grant
    Filed: July 26, 2001
    Date of Patent: November 11, 2008
    Assignee: Sumitomo Pharmaceuticals Company Limited
    Inventors: Toshihiro Noguchi, Akemi Baba, Mitsuharu Hanada
  • Publication number: 20080095532
    Abstract: In a point-to-multipoint network of an optical line terminal (OLT) and multiple optical network units (ONUS) wherein each ONU is enabled to send a signal only within a time period enabled for the ONU, the OLT (or a system installed therein) identifies a defective one of the ONUs. For each of a given series of time periods, the OLT measures an optical reception level of an optical fiber signal in the time period. The OLT stores, in advance, in a table at least the reception level of a received signal from each ONU in association with the ONU. The reception level is measured in a normal state where signals from the ONUs are exclusively received. For each of the given series of time periods, the OLT decides whether a signal from one of the ONUs associated with the time period is exclusively received with no collision with any other signal.
    Type: Application
    Filed: September 27, 2007
    Publication date: April 24, 2008
    Applicant: FUJITSU LIMITED
    Inventors: Katsuichi Yamaji, Toshimi Kida, Toshihiro Noguchi
  • Publication number: 20080031881
    Abstract: A medicament for treating cancer for use in combination therapy with an anti-HER2 antibody, which comprises amrubicin or a pharmaceutically acceptable salt thereof as an active ingredient.
    Type: Application
    Filed: June 11, 2007
    Publication date: February 7, 2008
    Applicant: Dainippon Sumitomo Pharma Co., Ltd.
    Inventors: Toshihiro NOGUCHI, Akemi Baba, Mitsuharu Hanada
  • Publication number: 20070230952
    Abstract: The hoses connected to parts of a photosensitive material processor, like to a processing tank, are formed from a styrene containing or olefin containing thermoplastic elastomer. Plasticizers such as those found in PVC hoses are not used in the material so cracking does not occur in the portions connecting the hoses to the processing tanks. Further, since it is not necessary to make the connecting portions of the processing tanks out of metal in order to prevent cracking, the manufacturing costs of the processor can be reduced.
    Type: Application
    Filed: November 2, 2006
    Publication date: October 4, 2007
    Inventors: Toshihiro Noguchi, Hideyuki Murakoshi
  • Patent number: 7091189
    Abstract: By using a combination of amrubicin or a pharmaceutically acceptable salt thereof with another medicament for treating lung cancer (irinotecan, vinorelbine, gemcitabine, etc.), it is intended to provide medicaments for treating lung cancer having an improved antitumor therapeutic effect on lung cancer and reduced side effects. Lung cancer can be effectively treated using these medicaments.
    Type: Grant
    Filed: March 17, 2003
    Date of Patent: August 15, 2006
    Inventors: Toshihiro Noguchi, Akemi Baba
  • Publication number: 20050119196
    Abstract: By using a combination of amrubicin or a pharmaceutically acceptable salt thereof with another medicament for treating lung cancer (irinotecan, vinorelbine, gemcitabine, etc.), it is intended to provide medicaments for treating lung cancer having an improved antitumor therapeutic effect on lung cancer and reduced side effects. Lung cancer can be effectively treated using these medicaments.
    Type: Application
    Filed: March 17, 2003
    Publication date: June 2, 2005
    Inventors: Toshihiro Noguchi, Akemi Baba
  • Publication number: 20040038913
    Abstract: Lung cancer can be treated effectively by combination of amrubicin or a pharmaceutically acceptable salt thereof with cisplatin.
    Type: Application
    Filed: July 17, 2003
    Publication date: February 26, 2004
    Inventors: Toshihiro Noguchi, Akemi Baba
  • Publication number: 20030157097
    Abstract: A medicament for treating cancer for use in combination therapy with an anti-HER2 antibody, which comprises amrubicin or a pharmaceutically acceptable salt thereof as an active ingredient.
    Type: Application
    Filed: April 21, 2003
    Publication date: August 21, 2003
    Inventors: Toshihiro Noguchi, Akemi Baba, Mitsuharu Hanada
  • Patent number: 6571114
    Abstract: This invention regarding the medical measurement apparatus includes an apparatus body capable of being held with a thumb and at least one of the subject testing-fingers, that is, the forefinger, the middle finger, the third finger, the fourth finger; a sensor slot bearing within a sensor in which the sensor slot is open at the side of the apparatus body capable of inserting the testing finger; a switch of the sensor in which the switch is controlled by the thumb and disposed at a prescribed position of the apparatus body; and a display device for indicating the result measured by the sensor in which the display device is arranged at the front surface of the apparatus body.
    Type: Grant
    Filed: June 4, 2001
    Date of Patent: May 27, 2003
    Assignee: Koike Medical Co., Ltd.
    Inventors: Kazuo Koike, Yasufumi Hisasue, Toshihiro Noguchi, Shoji Yokota
  • Patent number: 5742052
    Abstract: An infrared detector comprising an infrared detector element for generating an electrical signal, a support for the infrared detector element, and a circuit board for receiving the electrical signal from the infrared detector element. The support is formed integrally with the circuit board. The support comprises a matrix of composite material essentially consisting of one of thermosetting resins and thermoplastic resins having a thermal deformation temperature of at least 100.degree. C. and a tensile elastic modulus of at least 100 kgf/mm.sup.2, and of carbon fibers contained in the range of 10 to 40% by weight and dispersed in the matrix. The circuit board is formed with a through-hole having an inner surface processed so as to be electrically conductive.
    Type: Grant
    Filed: July 18, 1996
    Date of Patent: April 21, 1998
    Assignee: Sumitomo Metal Mining Co., Ltd.
    Inventors: Toshihiro Noguchi, Nobuo Kobayashi, Yukitoshi Tamura, Toshiei Matsuzaki